| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000013769 |
| Receipt No. | R000016073 |
| Scientific Title | Oral Immunotherapy for Hen's Egg, Cow's Milk, and Wheat allergic children at outpatient clinic. |
| Date of disclosure of the study information | 2014/04/21 |
| Last modified on | 2021/10/05 (Ver. 3) |
| Basic information | ||
| Public title | Oral Immunotherapy for Hen's Egg, Cow's Milk, and Wheat allergic children at outpatient clinic. | |
| Acronym | Outpatient Oral Immunotherapy | |
| Scientific Title | Oral Immunotherapy for Hen's Egg, Cow's Milk, and Wheat allergic children at outpatient clinic. | |
| Scientific Title:Acronym | Outpatient Oral Immunotherapy | |
| Region |
|
|
| Condition | ||
| Condition | food allergy | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate efficacy and safety of outpatient oral immunotherapy for food allergy focusing on target doses. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | The purpose of this study is to clarify dose dependent outcome, regarding tolerance acquisition and incidence rate of symptoms by outpatient oral immunotherapy.
Patients are enrolled in two groups, which are divided by target amounts of OIT ingestion as 100% or 25% of maximum ingestion amount. |
| Key secondary outcomes | To investigate the efficacy of oral immunotherapy, compared to natural course without the therapy.
To confirm the safety of outpatient oral immunotherapy for mild and moderate food allergic children. To analyze the reactivity for oral immunotherapy, stratified by their severity of food allergy. Regarding the OIT patients who haven't reached tolerance at 1 year follow up, they can continue OIT for longer period with their informed consent with its will for participation in advance. The outcome at 2 years' follow up is analyzed in addition to that at 1 year. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -but assessor(s) are blinded |
| Control | No treatment |
| Stratification | YES |
| Dynamic allocation | YES |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | YES |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | The target amount of ingestion, regarding tolerance acquisition, is defined one heated hen's egg, 100ml of cow's milk, and 100g of Japanese Udon noodles. | |
| Interventions/Control_2 | The maximum amount of ingestion at home is 100% amount of that in group A and 25% of that in group B, during one year oral immunotherapy. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Subjects, aged 3-15 years old, undergo oral food challenge within the 3 months before this trial.
They are confirmed mild or moderate positive objective symptoms caused by hen's egg, cow's milk, or wheat ingestion challenge. The threshold for eliciting positive symptoms is more than a thirty-second hen's egg and not greater than a quarter of that for egg allergic children. Also that for cow's milk is more than 3ml and not greater than 25ml, and that for wheat is more than 3g of Udon noodles and not greater than 25g of that. |
|||
| Key exclusion criteria | The threshold for eliciting positive symptoms is less than or equal to a thirty-second hen's egg, 3ml of cow's milk, or 3g of Udon noodles by oral food challenge test.
The subject who is treated by adrenaline injection at oral food challenge test just before this study. The subject who has not-well treated atopic dermatitis, bronchial asthma, or any underlying disease. The subject who is not appropriate for oral immunotherapy, judged by medical doctor. |
|||
| Target sample size | 100 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | National Hospital Organization Sagamihara National Hospital | ||||||
| Division name | Department of Allergy, Clinical Research Center for Allergy and Rheumatology | ||||||
| Zip code | |||||||
| Address | 18-1, sakuradai, minamiku, sagamiharashi, kanagawa, Japan, 252-0392. | ||||||
| TEL | 042-742-8311 | ||||||
| foodallergy@sagamihara-hosp.gr.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | National Hospital Organization Sagamihara National Hospital | ||||||
| Division name | Department of Allergy, Clinical Research Center for Allergy and Rheumatology | ||||||
| Zip code | |||||||
| Address | 18-1, sakuradai, minamiku, sagamiharashi, kanagawa, Japan, 252-0392. | ||||||
| TEL | 042-742-7311 | ||||||
| Homepage URL | |||||||
| foodallergy@sagamihara-hosp.gr.jp | |||||||
| Sponsor | |
| Institute | National Hospital Organization Sagamihara National Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Research grant by the Ministry of Health, Labour and Welfare of Japan |
| Organization | |
| Division | |
| Category of Funding Organization | |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 国立病院機構 相模原病院 小児科(神奈川県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016073 |